Prevalence and costs of multimorbidity by deprivation levels in the Basque Country: A population based study using health administrative databases

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Orueta, Juan F ^a   García Álvarez, Arturo ^b   García Goñi, Manuel ^c   Paolucci, Francesco ^d,e   Nuño Solinís, Roberto ^b  

^a Centro de Salud La Paz   (Spain)

^b O Berri Basque Institute for Healthcare Innovation   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^e NORTHUMBRIA UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; CHILD; CHRONIC DISEASE; COST BENEFIT ANALYSIS; CROSS-SECTIONAL STUDY; DEMOGRAPHY; ELECTRONIC MEDICAL RECORD; FACTUAL DATABASE; FEMALE; HEALTH CARE COST; HEALTH CARE DISPARITY; HEALTH CARE MANAGEMENT; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; OUTPATIENT CARE; POPULATION RESEARCH; PREDICTION; PRESCHOOL CHILD; PRIMARY HEALTH CARE; SCHOOL CHILD; SOCIAL STATUS; SPAIN; VERY ELDERLY; YOUNG ADULT;

AGED; AGED, 80 AND OVER; CHRONIC DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; FEMALE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS; MALE; PREVALENCE; SOCIAL CLASS; SOCIOECONOMIC FACTORS; SPAIN;

EID: 84896142656     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089787     Document Type: Article

References (40)

1. OECD (2011) Health Reform: Meeting the Challenge of Ageing and Multiple Morbidities. Paris: Organisation for Economic Co-operation and Development. Available: http://www.oecd-ilibrary.org/content/book/9789264122314-en. Accessed 14 May 2013.
2. Tinetti ME FT (2012) DEsigning health care for the most common chronic condition-multimorbidity. JAMA 307: 2493-2494. doi:10.1001/jama.2012.5265.
3. Vogeli C, Shields AE, Lee TA, Gibson TB, Marder WD, et al. (2007) Multiple chronic conditions: prevalence, health consequences, and implications for quality, care management, and costs. J Gen Intern Med 22 Suppl 3: 391-395. doi:10.1007/s11606-007-0322-1. (Pubitemid 350172457)
4. Boyd CM, Fortin M (2010) Future of Multimorbidity Research: How Should Understanding of Multimorbidity Inform Health System Design?. Public Health Reviews 32: 451-474. Available: http://core.kmi.open.ac.uk/display/964118. Accessed 25 April 2013.
5. Smith SM, Soubhi H, Fortin M, Hudon C, O'Dowd T (2012) Managing patients with multimorbidity: systematic review of interventions in primary care and community settings. BMJ 345: e5205-e5205. doi:10.1136/bmj.e5205.
6. Roland M, Paddison C (2013) Better management of patients with multimorbidity. BMJ 346: f2510-f2510. doi:10.1136/bmj.f2510.
7. Anderson G, Hopkins J (2011) The latest disease burden challenge: People with multiple chronic conditions, in OECD, Health Reform: Meeting the Challenge of Ageing and Multiple Morbidities, OECD Publishing. pp. 15-35. Available: http://www.oecd-ilibrary.org/content/chapter/9789264122314-4-en. Accessed 14 May 2013.
8. Van de ven WPMM, Ellis RP (2000) Chapter 14 Risk adjustment in competitive health plan markets. In: Anthony J. Culyer and Joseph PNewhouse, Handbook of Health Economics. Elsevier, Vol. Volume 1, Part A. pp. 755-845. Available: http://www.sciencedirect.com/science/article/pii/S1574006400801730. Accessed 25 April 2013.
9. Lehnert T, König H-H (2012) [Effects of multimorbidity on health care utilization and costs]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 55: 685-692. doi:10.1007/s00103-012-1475-6.
10. Naessens JM, Stroebel RJ, Finnie DM, Shah ND, Wagie AE, et al. (2011) Effect of multiple chronic conditions among working-age adults. Am J Manag Care 17: 118-122.
11. Yu W, Ravelo A, Wagner TH, Phibbs CS, Bhandari A, et al. (2003) Prevalence and costs of chronic conditions in the VA health care system. Med Care Res Rev 60: 146S-167S. (Pubitemid 36993500)
12. Charlson M, Charlson RE, Briggs W, Hollenberg J (2007) Can Disease Management Target Patients Most Likely to Generate High Costs? The Impact of Comorbidity. J Gen Intern Med 22: 464-469. doi:10.1007/s11606-007-0130-7. (Pubitemid 46941213)
13. Starfield B, Kinder K (2011) Multimorbidity and its measurement. Health Policy 103: 3-8. doi:10.1016/j.healthpol.2011.09.004.
14. Spanish Institute of Health Information: (2012) Spanish version (eCIE9MC) of the Electronic International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) (8th Ed., Version 1.1.0). Available: http://eciemaps.mspsi.es/ecieMaps/browser/index-9-2012.html. Accessed 14 March 2013.
15. The WHO Collaborating Centre for Drug Statistics Methodology (2012) International language for drug utilization research ATC/DDD. Available: http://www.whocc.no/atc-ddd-index/. Accessed 14 March 2013.
16. Johns Hopkins Bloomberg School of Public Health (2009) The Johns Hopkins ACG Case-Mix System Technical Reference Guide Manual Version 9.0. Baltimore, MD.
17. Nuño R, Piñera K (2010) Strategy for tackling the challenge of chronicity. Health Policy Monitor. Available: http://www.hpm.org/es/a16/1. pdf. Accessed 14 May 2013.
18. García-Goñi M, Hernández-Quevedo C, Nuño-Solinís R, Paolucci F (2012) Pathways towards chronic care-focused healthcare systems: evidence from Spain. Health Policy 108: 236-245. doi:10.1016/j.healthpol.2012.09.014.
19. Department of Health and Consumer Affairs of the Basque Government and Osakidetza (2010) A strategy to tackle the challenge of chronicity in the Basque country. Available: http://cronicidad.blog.euskadi.net/descargas/plan/ ChronicityBasqueCountry.pdf. Accessed 14 March 2013.
20. Weiner JP, Dobson A, Maxwell SL, Coleman K, Starfield B, et al. (1996) Risk-adjusted Medicare capitation rates using ambulatory and inpatient diagnoses. Health Care Financ Rev 17: 77-99.
21. O'Malley KJ, Cook KF, Price MD, Wildes KR, Hurdle JF, et al. (2005) Measuring Diagnoses: ICD Code Accuracy. Health Serv Res 40: 1620-1639. doi:10.1111/j.1475-6773.2005.00444.x. (Pubitemid 41434351)
22. Majeed A (2004) Sources, uses, strengths and limitations of data collected in primary care in England. Health Stat Q: 5-14.
23. Gorina Y, Kramarow EA (2011) Identifying chronic conditions in Medicare claims data: evaluating the Chronic Condition Data Warehouse algorithm. Health Serv Res 46: 1610-1627. doi:10.1111/j.1475-6773.2011.01277.x.
24. Orueta JF, Nuño-Solinis R, Mateos M, Vergara I, Grandes G, et al. (2012) Monitoring the prevalence of chronic conditions: which data should we use?. BMC Health Serv Res 12:365. doi: 10.1186/1472-6963-12-365.
25. Maio V, Yuen E, Rabinowitz C, Louis D, Jimbo M, et al.(2005) Using pharmacy data to identify those with chronic conditions in Emilia Romagna, Italy. J Health Serv Res Policy 10:232-238. doi: 10.1258/135581905774414259. (Pubitemid 41540275)
26. Wiréhn AB, Karlsson HM, Carstensen JM (2007) Estimating disease prevalence using a population-based administrative healthcare database. Scand J Public Health 35:424-431. doi: 10.1080/14034940701195230. (Pubitemid 47386793)
27. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, et al. (2012) Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. The Lancet 380: 37-43. doi:10.1016/S0140- 6736(12)60240-2.
28. Domínguez-Berjón MF, Borrell C, Cano-Serral G, Esnaola S, Nolasco A, et al. (2008) [Constructing a deprivation index based on census data in large Spanish cities(the MEDEA project)]. Gac Sanit 22: 179-187.
29. Basu A, Manning WG (2009) Issues for the next generation of health care cost analyses. S109-114.
30. Basu A, Rathouz PJ (2005) Estimating marginal and incremental effects on health outcomes using flexible link and variance function models. Biostat 6: 93- 109. doi:10.1093/biostatistics/kxh020.
31. Chen AY, Escarce JJ (2010) Family structure and childhood obesity, Early Childhood Longitudinal Study - Kindergarten Cohort. Prev Chronic Dis 7: A50.
32. Fitzmaurice GM, Laird Ware (2011) Applied longitudinal analysis. Hoboken, N.J.: Wiley.
33. Manning WG, Basu A, Mullahy J (2005) Generalized modeling approaches to risk adjustment of skewed outcomes data. 465-488.
34. Ramsey S, Willke R, Briggs A, Brown R, Buxton M, et al. (2005) Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCTCEA Task Force report. 521-533.
35. Martínez-Granado M, Greño P, Oleaga M (2012) The Basque Country, Spain: Self-Evaluation Report, OECD Reviews of Higher Education in Regional and City Development. Available: https://www1.oecd.org/edu/ highereducationandadultlearning/Basque%20Country%20Self%20Evaluation%20Report. pdf. Accessed 14 May 2013.
36. Gené-Badia J, Gallo P, Hernández-Quevedo C, García-Armesto S (2012) Spanish health care cuts: penny wise and pound foolish? Health Policy 106: 23-28. doi:10.1016/j.healthpol.2012.02.001.
37. Hjerpe P, Merlo J, Ohlsson H, Bengtsson Boström K, Lindblad U (2010) Validity of registration of ICD codes and prescriptions in a research database in Swedish primary care: a cross-sectional study in Skaraborg primary care database. BMC Med Inform Decis Mak 10: 23. doi:10.1186/1472-6947-10-23.
38. Cabrera-León A, Jadad AR, Nuño-Solinís R, Bernabéu-Wittel M, Morales-Asencio JM, et al. (2012) Improving care for people living with chronic diseases: Innovative examples from Spain. International Journal of Healthcare Management 5: 208-215. doi:10.1179/ 2047971912Y.0000000022.
39. Nuño Solinis R, Contel Segura JC, Orueta JF, García- Álvarez A, Lewis G (2013) Development and implementation of risk stratification tools. Available: http://oberri.org/wp-content/uploads/2013/03/ Stratification-monography.pdf. Accessed 14 May 2013.
40. Lewis GH (2010) "Impactibility models": identifying the subgroup of high-risk patients most amenable to hospital-avoidance programs. Milbank Q 88: 240-255. doi:10.1111/j.1468-0009.2010.00597.x.